The LBX Pharmacy Co., Ltd (listed on the Shanghai Stock Exchange with the stock code 603883 and the market value of over 22 billion yuan), is a large Sino-foreign joint venture pharmaceutical retail chain enterprise derived from a monomer private drugstore, and engages in pharmaceutical retail, wholesale and production. The company is headquartered at Changsha City, Hunan Province, with the total assets of 6.6 billion yuan. Its sales in 2017 reached 8.5 billion yuan. The company hires more than 18,000 employees.

At present, it boasts 18 provincial-level markets in Hunan, Shaanxi, Zhejiang, Jiangxi, Guangxi, Shandong, Hebei, Guangdong, Tianjin, Shanghai, Hubei, Henan, Beijing, Jiangsu, Anhui, Gansu, Inner Mongolia and Ningxia and more than 3,000 drugstores in more than 80 cities. The pharmacy giant operates 45,600 drug specifications, the drug categories of which include Chinese patent medicine, Western patent medicine, traditional Chinese medicine decoction pieces, heh-keeping Chinese medicine, heh equipment, heh food, common food, personal-care product, articles for daily use. With its own subsidiaries such as YST PHARMA, Baixingtang Chinese Medical Centre, LBX Diabetes Intervention Centre, it engages in drug retailing, wholesale and production of drugs, and vigorously promotes the e-commerce O2O and other businesses such as "LBX Heh Pharmacy" franchises, DTP professional pharmacy and so on.